The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
about
Immunotherapy of Prostate Cancer: Facts and Hopes.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaRadium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases.Promising immunotherapy for prostate cancer.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).Impact of curative radiotherapy on the immune status of patients with localized prostate cancer
P2860
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@en
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@nl
type
label
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@en
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@nl
prefLabel
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@en
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@nl
P2093
P2860
P1476
The Society for Immunotherapy ...... eatment of prostate carcinoma.
@en
P2093
Charles G Drake
Daniel P Petrylak
David J Peace
Douglas G McNeel
Hank Porterfield
James L Gulley
Johannes Vieweg
Lawrence Fong
Mark N Stein
Neal D Shore
P2860
P2888
P356
10.1186/S40425-016-0198-X
P577
2016-12-20T00:00:00Z